The U.S. Food and Drug Administration (FDA) has cleared Elucid's FFR-IQ software for the noninvasive estimation of fractional flow reserve from coronary CT angiography (FFR-CT). The artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results